In silico prediction of drug-binding strengths to human serum albumin

Medicinal Research Reviews

Volumn 23, Issue 3, 2003, Pages 275-301

  Colmenarejo, Gonzalo ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

ADME prediction; Cheminformatics; Human serum albumin; QSAR

Indexed keywords

DRUG; HUMAN SERUM ALBUMIN;

BINDING AFFINITY; COMPUTER MODEL; CRYSTAL STRUCTURE; DISULFIDE BOND; DRUG BINDING AFFINITY; DRUG BINDING SITE; DRUG DESIGN; DRUG INFORMATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; FATTY ACID BINDING SITE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR MODEL; PHARMACODYNAMICS; PHARMACOKINETICS; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

BINDING SITES; CHROMATOGRAPHY, AFFINITY; HUMANS; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SERUM ALBUMIN;

EID: 0037404491     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10039     Document Type: Review

References (55)

1. Blake JF. Chemoinformatics - Predicting the physicochemical properties of "drug-like" molecules. Curr Opin Biotechnol 2000;11:104-107.
2. Butina D, Segall MD, Frankcombe K. Predicting ADME properties in silico: Methods and models. Drug Discovery Today 2002;7:S83-S88.
3. Prentis RA, Lis Y, Walker SR. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). Br J Clin Pharmacol 1988;25:387-396.
4. Hervé F, Urien S, Albengres E, Duché JC, Tillement J. Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Clin Pharmacokinet 1994;26:44-58.
5. Henrik V. Reversible ligand binding to human serum albumin: Theoretical and clinical aspects. Danish Med Bull 1999;46:379-399.
6. Carter DC, Ho JX. Structure of serum albumin. Adv Protein Chem 1994;45:152-203.
7. Rang HP, Dale MM, Ritter JM. Pharmacology. Edinburgh: Churchill Livingstone. 1999.
8. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL. Cheminformatic models to predict binding affinities to human serum albumin. J Med Chem 2001;44:4370-4378.
9. Galliano M, Kragh-Hansen U, Tarnoky AL, Chapman JC, Campagnoli M, Minchiotti L. Genetic variants showing apparent hot-spots in the human serum albumin gene. Clinica Chimica Acta 1999;289:45-55.
10. Cistola D. Fat sites found! Nat Struct Biol 1998;5:751-753.
11. Sudlow G, Birkett DJ, Wade DN. Characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 1975;11:824-832.
12. Sudlow G, Birkett DJ, Wade DN. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 1976;12:1052-1061.
13. McLachlan AD, Walker JE. Evolution of serum albumin. J Mol Biol 1977;112:543-558.
14. Carter DC, He X-M, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY. Three-dimensional structure of human serum albumin. Science 1989;244:1195-1198.
15. Carter DC, He X-M. Structure of human serum albumin. Science 1990;249:302-303.
16. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 1992;358:209-215.
17. Curry S, Mankelkow H, Brick P, Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 1998;5:827-835.
18. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng 1999;12:439-446.
19. Bhattacharya AA, Grune T, Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 2000;303:721-732.
20. Bhattacharya AA, Curry S, Franks NP. Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem 2000;275:38731-38738.
21. Petitpas I, Bhattacharya AA, Twine S, East M, Curry S. Crystal structure analysis of warfarin binding to human serum albumin. Anatomy of drug site I. J Biol Chem 2001;276:22804-22809.
22. Petitpas I, Grüne T, Bhattacharya AA, Curry S. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol 2001;314:955-960.
23. Vorum H, Honore B. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy. J Pharm Pharmacol 1996;48:870-875.
24. Sato H, Honore B, Brodersen R. Multiple binding of bilirubin to human serum albumin and cobinding with laurate. Arch Biochem Biophys 1988;260:811-821.
25. Ivarsen R, Brodersen R. Displacement of bilirubin from adult and newborn serum albumin by a drug and fatty acid. Dev Pharmacol Ther 1989;12:19-29.
26. Wanwimolruk S, Birkett DJ, Brooks PM. Structural requirements for drug binding to site II on human serum albumin. Mol Pharmacol 1983;24:458-463.
27. Noctor TA, Wainer IW, Hage DS. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. J Chromatogr 1992;577:305-315.
28. Pacifici GM, Viani A. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clin Pharmacokinet 1992;23:449-468.
29. Hage D. High-performance affinity chromatography: A powerful tool for studying serum protein binding. J Chromatogr B 2002;768:3-30.
30. Domenici E, Bertucci C, Salvadori P, Félix G, Cahagne I, Motellier S, Wainer IW. Synthesis and chromatographic properties of an HPLC chiral stationary phase based upon human serum albumin. Chromatographia 1990;29:170-176.
31. Domenici E, Bertucci C, Salvadori P, Motellier S, Wainer IW. Immobilized serum albumin: Rapid HPLC probe for stereoselective protein-binding interactions. Chirality 1990;2:263-268.
32. Loun B, Hage DS. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin. J Chromatogr 1992;579:225-235.
33. Tittelbach V, Jaroniec M, Gilpin RK. Synthesis and characterization of silica-immobilized serum albumin stationary phases for HPLC. J Liq Chromatogr Relat Technol 1996;19:2943-2965.
34. Tittelbach V, Gilpin RK. Species dependency of the liquid chromatographic properties of silica-immobilized serum albumins. Anal Chem 1995;67:44-47.
35. Millot MC, Sebille B, Mangin C. Enantiomeric properties of human albumin immobilized on porous silica supports coated with polymethacryloyl chloride. J Chromatogr A 1997;776:37-44.
36. Talbe NL, Millot MC, Sebille B. Enantioselectivity properties of human serum albumin immobilized on anion-exchangers based on polyvinylimidazole-coated silica. Effect of protein loading on separation properties. J Chromatogr A 1997;776:45-53.
37. Sengupta A, Hage DS. Characterization of minor site probes for human serum albumin by high-performance affinity chromatography. Anal Chem 1999;71:3821-3827.
38. Hage DS, Austin J. High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-protein binding. J Chromatogr B 2000;739:39-54.
39. Loun B, Hage DS. Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized serum albumin. Anal Chem 1994;66:3814-3822.
40. Yang J, Hage DS. Role of binding capacity versus binding strength in the separation of chiral compounds on protein-based high-performance liquid chromatography columns. Interactions of D- and L-tryptophan with human serum albumin. J Chromatogr A 1996;725:273-285.
41. Yang J, Hage DS. Effect of mobile phase composition on the binding kinetics of chiral solutes on a protein-based high-performance liquid chromatography column: Interactions of D- and L-tryptophan with immobilized human serum albumin. J Chromatogr A 1997;766:15-25.
42. Talbert A, Tranter GE, Holmes E, Francis PL. Determination of drug-plasma protein binding kinetics and equilibria by chromatographic profiling: Exemplification of the method using L-tryptophan and albumin. Anal Chem 2002;74:446-452.
43. Kaliszan R, Noctor TAG, Wainer IW. Quantitative structure-enantioselective retention relationships for the chromatography of 1,4-benzodiazepines on a human serum albumin based HPLC chiral stationary phase: An approach to the computational prediction of retention and enantioselectivity. Chromatographia 1992;33:546-550.
44. Markuszewski M, Kaliszan R. Quantitative structure-retention relationships in affinity high-performance liquid chromatography. J Chromatography B 2002;768:55-66.
45. Kaliszan R. Retention data from affinity high-performance liquid chromatography in view of chemometrics. J Chromatography B 1998;715:229-244.
46. Ashton DS, Beddell C, Ray AD, Valkó K. Quantitative structure-retention relationships of acyclovir esters using immobilised albumin high-performance liquid chromatography and reversed-phase high-performance liquid chromatography. J Chromatography A 707:367-372.
47. Ashton DS, Beddell CR, Cockerill GS, Gohil K, Gowrie C, Robinson JE, Slater MJ, Valko K. Binding measurements of indolocarbazole derivatives to immobilised human serum albumin by high-performance liquid chromatography. J Chromatography B 1996;677:194-198.
48. Andrisano V, Booth TD, Cavrini V, Wainer IW. Enantioselective separation of chiral arylcarboxylic acids on an immobilized human serum albumin chiral stationary phase. Chirality 1997;9:178-183.
49. Andrisano V, Bertucci C, Cavrini V, Recanatini M, Cavalli A, Varoli L, Felix G, Wainer IW. Stereoselective binding of 2,3-substituted 3-hydroxypropionic acids on an immobilized human serum albumin chiral stationary phase: Stereochemical characterization and quantitative structure-retention relationship study. J Chromatogr A 2000;876:75-86.
50. Andrisano V, Gotti R, Recanatini M, Cavalli A, Varoli L, Bertucci C. Stereoselective binding of 2-(4-biphenylyl)-3-substituted-3-hydroxypropionic acids on an immobilised human serum albumin chiral stationary phase. J Chromatography B 2002;768:137-145.
51. Hanai T, Miyazaki R, Kinoshita T. Quantitative analysis of human serum albumin-drug interactions using reversed-phase and ion-exchange liquid chromatography. Anal Chim Acta 1999;378:77-82.
52. Hanai T, Koseki A, Yoshikawa R, Ueno M, Kinoshita T, Homma H. Prediction of human serum albumin-drug binding affinity without albumin. Anal Chim Acta 2002;454:101-108.
53. Wold S. Validation of QSAR's. Quant Struct-Act Relat 1991;10:191-193.
54. QSAR + 4.5 Manual; San Diego, CA: MSI. 2000.
55. Friedman JH. Multivariate adaptive regression splines. Ann Statist 1991;19:1-141.